Navigation Links
Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams
Date:2/7/2008

CHAPEL HILL, N.C., Feb. 7 /PRNewswire/ -- Selecting and deploying cross- functional, yet sufficiently specialized, brand teams is a new challenge for marketing leaders at pharmas and biotechs. However, best-in-class pharma and biotech firms' brand teams share similar structure, composition, and responsibilities -- all detailed in a new benchmarking report by pharmaceutical research leader Best Practices, LLC.

According to research findings, most brands have a core team of three to 10 people and 86 percent of the pharma and biotech companies reported that the brand team leader sits in the marketing function.

The study, "Best Practices in Designing Effective Brand Teams: Brand Governance and Brand Team Management," yields insights into key benchmarks and strategies for designing effective brand teams. Managers and executives involved with brand teams can use this report to assess their teams and compare structure and governance styles of leading pharmaceutical and biotech brand teams.

A complimentary excerpt of the research report with sample key findings and metrics is reserved for you at http://www3.best-in-class.com/rr908.htm.

The study includes insights gleaned from survey results from brand team managers and executives representing 22 brands in 26 different companies. Deep-dive interviews to flesh out best practices were conducted with 10 managers from the benchmark partners, which included Abbott, Amylin, Bayer, Genentech, GSK, Roche, Novartis and Wyeth.
The comprehensive report reveals findings around key topics, including:

-- Staffing and functional representation for brand teams

-- Brand team operations, decision rights and responsibilities

-- Reporting relationships

-- Performance-based compensation and reviews

-- Brand performance measures

For a detailed report overview and sample metrics, download the report excerpt at http://www3.best-in-class.com/rr908.htm.

For questions or additional information on Best Practices, LLC's other products and services, please call Anna Buhr at 919-809-7560 or email abuhr@best-in-class.com.

If this study is not meeting your current business needs, inquire about starting your own research study or internet survey. Our custom client research will answer your pressing business questions and provide you with actionable insights and process best practices. Please contact Anna Buhr, Manager of Research Operations at abuhr@best-in-class.com to learn more about custom research in HR and other business fields.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
2. NuView Radiopharmaceuticals, Inc. Secures Exclusive Rights From Thomas Jefferson University for a Tumor-Specific Imaging Agent for the Diagnosis of Breast and Prostate Cancers
3. West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference
4. MAP Pharmaceuticals Announces Resignation of Chief Medical Officer
5. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
6. NPS Pharmaceuticals to Present at BIO CEO & Investor Conference
7. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
8. Poniard Pharmaceuticals Announces Upcoming Conference Participation
9. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
10. Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
11. NxStage Medical to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... ... If you are feeling that your clothes are a tad snug, the ... Center for Disease Control and Prevention (CDC), 34.9% of U.S. adult women are overweight. ... some of the leading causes of preventable death. February is heart health month ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local ... the greater Venice, FL area, has initiated a fundraiser for a two year ... just four days after Christmas. To support this beautiful child who is facing ...
(Date:2/8/2016)... ... February 08, 2016 , ... Eating disorders and post-traumatic ... of women and men with eating disorders report a history of trauma, research ... development of an eating disorder. , At the 2016 iaedp Symposium, the ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... to share this important news! AHCC and the Home Health and Hospice ICD-10 ... CMS' designee for official ICD coding guidance and clarifications, to address concerns over ...
(Date:2/8/2016)... ... 08, 2016 , ... The schedule is now online for the ... Conference, which is being held May 25-29 at the Loews Chicago O’Hare Hotel, continues ... and causes of chronic illness in children. , Very recent articles have cited 1 ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... ORLANDO, Fla. , Feb. 8, 2016 ... and marketing high performance apparel for healthcare and other ... Bold Chief Executive Officer. He replaces Dale ... and remains Chairman. Mr. Bold is also joining Vestagen,s ... in a new class of active barrier technologies that ...
(Date:2/8/2016)... 2016  Dynatronics Corporation (NASDAQ: DYNT ), ... and rehabilitation equipment for the physical therapy, sports ... football team for winning the 2016 World Championship. ... and Chief Executive Officer.  "The Broncos have a ... to enhancing their athletic achievements with our products ...
(Date:2/8/2016)... 8, 2016 Palatin Technologies, Inc. (NYSE ... peptide therapeutics for the treatment of diseases with ... today that the United States Patent and Trademark ... for U.S. Patent Application Serial Number 14/313,258 (the ... of treating female sexual dysfunction using the formulation ...
Breaking Medicine Technology: